New Multiple-Source Generics Pricing Policy

For information on this policy, including the calculation of the cost reduction factor, please see PharmaCare Newsletter 08-012.

Products currently subject to a cost reduction factor

The following products are subject to a cost reduction factor. For more information, click on a drug name below.

New products which may become subject to a cost reduction factor

The following product(s) are not currently subject to a cost reduction factor. A cost reduction factor will be applied only if a second generic version of the drug becomes a PharmaCare benefit.

For more information, click on a drug name below.